Business
Dewmar International BMC, Inc. (DEWM) Board Member Named as Contributing Author to an Application Filed by a Louisiana Company for the Second and Final Cannabis Cultivation License in Louisiana
Dewmar International BMC, Inc. (DEWM) Board Member Named as Contributing Author to an Application Filed by a Louisiana Company for the Second and Final Cannabis Cultivation License in Louisiana.
About this update from Dewmar Intl Bmc Inc
[{"type":"text","content":"\n \n \n Dewmar International BMC, Inc. (DEWM) Board Member Named as Contributing Author to an Application Filed by a Louisiana Company for the Second and Final Cannabis Cultivation License in Louisiana\n \n \nDewmar International BMC, Inc. (DEWM) Board Member Named as Contributing Author to an Application Filed by a Louisiana Company for the Second and Final Cannabis Cultivation License in Louisiana\n\nDewmar Board Member and Baton Rouge Native Physician, Dr. Derrick Brooks, Named as Key Personnel to Provide Expert Advice in Medical Cannabis Formulation, Research and Clinical Practices\n\n \n DENVER, CO--(Marketwired - Jul 17, 2017) - Dewmar International BMC, Inc. (OTC PINK: DEWM) (the \"Company\") today announced that its Board Member, Dr. Derrick Brooks, M.D. is a contributing author to an application to assist a Louisiana company in the execution and pursuit of a contract to be named the sole operator of a Medical Marijuana Cultivation and Production Facility Operator for Southern University A&M.\n Dr. Brooks has been a member of the Dewmar Board of Directors for more than 5 years as the Company's medical liaison for functional food and beverage product review. He has taken particular interest in the positive therapeutic outcomes of cannabis, CBD and THC formulations.\n \"I am happy to be appointed as a key personnel medical practitioner with a very strong and diverse team of other professionals and healthcare experts in order to pursue the second and final cannabis cultivation and research license in the state of Louisiana,\" said Dr. Brooks. \"My focus will be in general cannabis therapeutic dosing for pain management; while medical director Dr. Donisha Dunn-Lombard's focus will be on psychiatry, PTSD and pain. Dr. Ato Wright will focus on various types of cancer and oncology therapies. Our unique team of local physicians was organized by the Dewmar International executive staff.\" \n As a company, Dewmar International identified a critical area of intellectual property that they believe can secure several of the largest healthcare markets existing in the country today to share with Dr. Brooks to help Southern University monetize its cannabis research and development plan.\n About Dewmar International BMC, Inc.\n Dewmar International BMC, Inc. is a certified service-disabled veteran-owned business concern, new pr...